China In Vitro Diagnostics Market Outlook to 2016

Report Summary

GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2016” provides key market data on the China In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for In Vitro Diagnostics (IVD) market categories  clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the China In Vitro Diagnostics (IVD) market.
• Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the China In Vitro Diagnostics (IVD) competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
    1.1 List of Tables
    1.2 List of Figures

2 Introduction
    2.1 What is This Report About?

3 In Vitro Diagnostics In China
    3.1 In Vitro Diagnostics, Market Segmentation
    3.2 In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016
    3.3 In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009
    3.4 In Vitro Diagnostics Market, China, Category Contribution (%), 2009
    3.5 In Vitro Diagnostics, China, Company Share (2008-2009)

4 Clinical Chemistry In China
    4.1 Clinical Chemistry, Market Segmentation
    4.2 Clinical Chemistry Market, China, Revenue Mix ($m), 2009
    4.3 Clinical Chemistry Market, China, Category Contribution (%), 2009
    4.4 Clinical Chemistry Overall Revenue (2002-2016)
    4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)
    4.4.2 Urine Analysis Revenue (2002-2016)
    4.5 Clinical Chemistry Distribution Share (2008-2009)
    4.6 Clinical Chemistry, China, Company Share (2008-2009)

5 Genetic Testing In China
    5.1 Genetic Testing, Market Segmentation
    5.2 Genetic Testing Market, China, Revenue Mix ($m), 2009
    5.3 Genetic Testing Market, China, Category Contribution (%), 2009
    5.4 Genetic Testing Overall Revenue (2002-2016)
    5.5 Genetic Testing Distribution Share (2008-2009)
    5.6 Genetic Testing, China, Company Share (2008-2009)

6 Haematology In China
    6.1 Haematology, Market Segmentation
    6.2 Haematology Market, China, Revenue Mix ($m), 2009
    6.3 Haematology Market, China, Category Contribution (%), 2009
    6.4 Haematology Overall Revenue (2002-2016)
    6.4.1 Haematology Reagents Revenue (2002-2016)
    6.4.2 Immunohaematology Revenue (2002-2016)
    6.4.3 Haemostasis Revenue (2002-2016)
    6.4.4 Haematology Rapid Tests Revenue (2002-2016)
    6.4.5 Haematology Cell Counters Revenue (2002-2016)
    6.5 Haematology Distribution Share (2008-2009)
    6.6 Haematology, China, Company Share (2008-2009)

7 Histology And Cytology In China
    7.1 Histology and Cytology, Market Segmentation
    7.2 Histology and Cytology Market, China, Revenue Mix ($m), 2009
    7.3 Histology And Cytology Market, China, Category Contribution (%), 2009
    7.4 Histology And Cytology Overall Revenue (2002-2016)
    7.4.1 Histology Revenue (2002-2016)
    7.5 Histology And Cytology Distribution Share (2008-2009)
    7.6 Histology And Cytology, China, Company Share (2008-2009)

8 Immuno Chemistry In China
    8.1 Immuno Chemistry, Market Segmentation
    8.2 Immuno Chemistry Market, China, Revenue Mix ($m), 2009
    8.3 Immuno Chemistry Market, China, Category Contribution (%), 2009
    8.4 Immuno Chemistry Overall Revenue (2002-2016)
    8.4.1 Disease Specific Immunochemistry Revenue (2002-2016)
    8.4.2 Drug Related Testing Revenue (2002-2016)
    8.4.3 Endocrinology Tests Revenue (2002-2016)
    8.4.4 Immunochemistry Analyzers Revenue (2002-2016)
    8.5 Immuno Chemistry Distribution Share (2008-2009)
    8.6 Immuno Chemistry, China, Company Share (2008-2009)

9 Infectious Immunology In China
    9.1 Infectious Immunology, Market Segmentation
    9.2 Infectious Immunology Market, China, Revenue Mix ($m), 2009
    9.3 Infectious Immunology Market, China, Category Contribution (%), 2009
    9.4 Infectious Immunology Overall Revenue (2002-2016)
    9.5 Infectious Immunology Distribution Share (2008-2009)
    9.6 Infectious Immunology, China, Company Share (2008-2009)

10 Microbiology Culture In China
    10.1 Microbiology Culture, Market Segmentation
    10.2 Microbiology Culture Market, China, Revenue Mix ($m), 2009
    10.3 Microbiology Culture Market, China, Category Contribution (%), 2009
    10.4 Microbiology Culture Overall Revenue (2002-2016)
    10.4.1 Microbiology Analyzers Revenue (2002-2016)
    10.5 Microbiology Culture Distribution Share (2008-2009)
    10.6 Microbiology Culture, China, Company Share (2008-2009)

11 Overview of Key Companies in China In Vitro Diagnostics Market
    11.1 F. Hoffmann-La Roche Ltd.
    11.1.1 Company Overview
    11.1.2 Share in the China In Vitro Diagnostics Market
    11.2 Siemens Healthcare
    11.2.1 Company Overview
    11.2.2 Share in the China In Vitro Diagnostics Market
    11.3 Abbott LaboratoriesCompany Overview
    11.3.1 Share in the China In Vitro Diagnostics Market
    11.4 Beckman Coulter, Inc.
    11.4.1 Company Overview
    11.4.2 Share in the China In Vitro Diagnostics Market
    11.5 Sysmex Corporation
    11.5.1 Company Overview
    11.5.2 Share in the China In Vitro Diagnostics Market
    11.6 Mindray Medical International Limited
    11.6.1 Company Overview
    11.6.2 Share in the China In Vitro Diagnostics Market
    11.7 OLYMPUS CORPORATION
    11.7.1 Company Overview
    11.8 Inverness Medical Innovations, Inc.
    11.8.1 Company Overview
    11.9 Becton, Dickinson and Company
    11.9.1 Company Overview
    11.10 bioMerieux S.A.
    11.10.1 Company Overview
    11.11 Bio-Rad Laboratories, Inc.
    11.11.1 Company Overview
    11.12 Hologic, Inc.
    11.12.1 Company Overview
    11.13 Ventana Medical Systems, Inc.
    11.13.1 Company Overview
    11.14 Ortho-Clinical Diagnostics Inc.
    11.14.1 Company Overview
    11.15 DiaSorin S.p.A
    11.15.1 Company Overview
    11.16 Qiagen N.V.
    11.16.1 Company Overview
    11.17 Gen-Probe Incorporated
    11.17.1 Company Overview
    11.18 Phadia AB
    11.18.1 Company Overview
    11.19 Chengdu Perlong Medical Equipment Co., Ltd.
    11.19.1 Company Overview
    11.20 Shanghai Kehua Bio-engineering Co., Ltd.
    11.20.1 Company Overview
    11.21 China Medical Technologies, Inc.
    11.21.1 Company Overview
    11.22 Shanghai Genomics, Inc.
    11.22.1 Company Overview
    11.23 Beijing Chemclin Biotech Co., Ltd.
    11.23.1 Company Overview
    11.24 Beijing Pason Pharmaceuticals Inc.
    11.24.1 Company Overview
    11.25 Jingmei Biotech Co.,Ltd.
    11.25.1 Company Overview
    11.26 Beijing Bio-Ekon Biotechnology Co., Ltd.
    11.26.1 Company Overview
    11.27 China Sky One Medical, Inc.
    11.27.1 Company Overview
    11.28 Beijing Sekisui Trank Medical Technology Co., Ltd.
    11.28.1 Company Overview
    11.29 Shanghai Xunda Medical Instrument Co.,Ltd
    11.29.1 Company Overview
    11.30 Shanghai Fosun Medical Technology Development Co., Ltd.
    11.30.1 Company Overview
    11.31 Sichuan Nigale Biomedical Inc.
    11.31.1 Company Overview
    11.32 URIT Medical Electronic Group Co., Ltd
    11.32.1 Company Overview
    11.33 Rayto Life and Analytical Sciences Co., Ltd.
    11.33.1 Company Overview
    11.34 Bioson Corporation
    11.34.1 Company Overview
    11.35 Da An Gene Co., Ltd.
    11.35.1 Company Overview
    11.36 Shenzhen PG Biotech Co., Ltd.
    11.36.1 Company Overview
    11.37 Harbin First Bio-Engineering Co., Ltd
    11.37.1 Company Overview
    11.38 Beijing Shining Sun Technology Co., Ltd.
    11.38.1 Company Overview
    11.39 InTec Products, Inc
    11.39.1 Company Overview
    11.40 Zhongshan Bio-Tech Co., Ltd
    11.40.1 Company Overview
    11.41 Beijing BGI-GBI Biotech Co.,Ltd.
    11.41.1 Company Overview
    11.42 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.,
    11.42.1 Company Overview
    11.43 GUANG ZHOU BGH BIOCHEMICAL CO.,LTD
    11.43.1 Company Overview

12 In Vitro Diagnostics Market Pipeline Products
    12.1 Clinical Chemisty Market Pipeline Products
    12.2 Immuno Chemistry Market Pipeline Products
    12.3 Haematology Market Pipeline Products
    12.4 Infectious Immunology Market Pipeline Products
    12.5 Microbiology Culture Market Pipeline Products
    12.6 Histology and Cytology Market Pipeline Products
    12.7 Genetic Testing Market Pipeline Products

13 Financial Deals Landscape
    13.1 Acquisition
    13.1.1 CCS Capital to Acquire Beijing Biochem Hengye Science & Technology Development
    13.1.2 bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai)
    13.1.3 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience
    13.2 Partnerships
    13.2.1 QIAGEN Enters Into Distribution Agreement With Celera
    13.2.2 Sequenom Enters Into Licensing Agreement With Optherion
    13.2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
    13.2.4 Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech
    13.2.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics
    13.2.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
    13.2.7 DxS Signs Cross-Licensing Agreement With Epigenomics

14 Recent Developments
    14.1 Strategy and Business Planning
    14.1.1 Sep 08, 2009: Qiagen Inaugurates New Asia Headquarters In Shanghai
    14.2 Legal and Regulatory
    14.2.1 Mar 08, 2010: Chinmax Medical Systems Files Complaint In China Against Inverness Medical Beijing Over Distribution Rights
    14.3 Product News
    14.3.1 Jun 09, 2010: China Medical Technologies Receives SFDA Approval For Its SPR-Based HPV-DNA Chip
    14.3.2 Apr 14, 2010: HairDX Forms Alliance With GBIL To Distribute HairDX Genetic Hair Loss Tests In Hong Kong And Singapore
    14.3.3 Dec 01, 2009: China Sky One Medical Distributes AMI Diagnostic Kit And Human Urinary Albumin Elisa Kit In Southeast Asia Through MDK
    14.3.4 Nov 25, 2009: China Sky One Medical Achieves Milestone For Its Two New Biological Testing Kits
    14.3.5 Oct 19, 2009: China Medical Technologies Receives SFDA Clearance For SPR System

15 Appendix
    15.1 Definitions of Markets Covered in the Report
    15.1.1 In Vitro Diagnostics
    15.2 Research Methodology
    15.3 Secondary Research
    15.4 Primary Research
    15.5 Models
    15.6 Forecasts
    15.7 Expert Panels
    15.8 GlobalData Consulting
    15.9 Currency Conversion
    15.10 Contact Us
    15.11 Disclaimer

List of Tables

    Table 1: In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016
    Table 2: In Vitro Diagnostics Market, China, Category Contribution (%), 2009
    Table 3: In Vitro Diagnostics, China, Cross-Category Analysis, 2002-2016
    Table 4: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2002-2009
    Table 5: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2009-2016
    Table 6: In Vitro Diagnostics, China, Company Share by Revenue ($m), 2008-2009
    Table 7: Clinical Chemistry Market, China, Category Contribution (%), 2009
    Table 8: Clinical Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009
    Table 9: Clinical Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Table 10: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 11: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 12: Urine Analysis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 13: Urine Analysis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 14: Clinical Chemistry, China, Distribution Share by Revenue ($m), 2008-2009
    Table 15: Clinical Chemistry, China, Company Share by Revenue ($m), 2008-2009
    Table 16: Genetic Testing Market, China, Category Contribution (%), 2009
    Table 17: Genetic Testing, China, Revenue ($m) by Segment, Historic, 2002-2009
    Table 18: Genetic Testing, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Table 19: Genetic Testing, China, Distribution Share by Revenue ($m), 2008-2009
    Table 20: Genetic Testing, China, Company Share by Revenue ($m), 2008-2009
    Table 21: Haematology Market, China, Category Contribution (%), 2009
    Table 22: Haematology, China, Revenue ($m) by Segment, Historic, 2002-2009
    Table 23: Haematology, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Table 24: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 25: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 26: Immunohaematology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 27: Immunohaematology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 28: Haemostasis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 29: Haemostasis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 30: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 31: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 32: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 33: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 34: Haematology, China, Distribution Share by Revenue ($m), 2008-2009
    Table 35: Haematology, China, Company Share by Revenue ($m), 2008-2009
    Table 36: Histology And Cytology Market, China, Category Contribution (%), 2009
    Table 37: Histology And Cytology, China, Revenue ($m) by Segment, Historic, 2002-2009
    Table 38: Histology And Cytology, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Table 39: Histology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 40: Histology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 41: Histology And Cytology, China, Distribution Share by Revenue ($m), 2008-2009
    Table 42: Histology And Cytology, China, Company Share by Revenue ($m), 2008-2009
    Table 43: Immuno Chemistry Market, China, Category Contribution (%), 2009
    Table 44: Immuno Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009
    Table 45: Immuno Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Table 46: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 47: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 48: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 49: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 50: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 51: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 52: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 53: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 54: Immuno Chemistry, China, Distribution Share by Revenue ($m), 2008-2009
    Table 55: Immuno Chemistry, China, Company Share by Revenue ($m), 2008-2009
    Table 56: Infectious Immunology Market, China, Category Contribution (%), 2009
    Table 57: Infectious Immunology, China, Revenue ($m) by Segment, Historic, 2002-2009
    Table 58: Infectious Immunology, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Table 59: Infectious Immunology, China, Distribution Share by Revenue ($m), 2008-2009
    Table 60: Infectious Immunology, China, Company Share by Revenue ($m), 2008-2009
    Table 61: Microbiology Culture Market, China, Category Contribution (%), 2009
    Table 62: Microbiology Culture, China, Revenue ($m) by Segment, Historic, 2002-2009
    Table 63: Microbiology Culture, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Table 64: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Table 65: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Table 66: Microbiology Culture, China, Distribution Share by Revenue ($m), 2008-2009
    Table 67: Microbiology Culture, China, Company Share by Revenue ($m), 2008-2009
    Table 68: Clinical Chemisty Market Pipeline Products
    Table 69: Immuno Chemistry Market Pipeline Products
    Table 70: Haematology Market Pipeline Products
    Table 71: Infectious Immunology Market Pipeline Products
    Table 72: Microbiology Culture Market Pipeline Products
    Table 73: Histology and Cytology Market Pipeline Products
    Table 74: Genetic Testing Market Pipeline Products
    Table 75: CCS Capital To Acquire Beijing Biochem Hengye Science & Technology Development
    Table 76: bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai)
    Table 77: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience
    Table 78: QIAGEN Enters Into Distribution Agreement With Celera
    Table 79: Sequenom Enters Into Licensing Agreement With Optherion
    Table 80: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
    Table 81: Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech
    Table 82: OraSure Technologies Enters Into An Agreement With Roche Diagnostics
    Table 83: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
    Table 84: DxS Signs Cross-Licensing Agreement With Epigenomics
    Table 85: USD to Local Currency, China, Average Actual Rate 2002-2009

List of Figures

    Figure 1: In Vitro Diagnostics, Market Segmentation
    Figure 2: In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016
    Figure 3: In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009
    Figure 4: In Vitro Diagnostics Market, China, Category Contribution (%), 2009
    Figure 5: In Vitro Diagnostics, China, Cross-Category Analysis, 2002-2016
    Figure 6: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2002-2009
    Figure 7: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2009-2016
    Figure 8: In Vitro Diagnostics, China, Company Share (%), 2009
    Figure 9: Clinical Chemistry, Market Segmentation
    Figure 10: Clinical Chemistry Market, China, Revenue Mix ($m), 2009
    Figure 11: Clinical Chemistry Market, China, Category Contribution (%), 2009
    Figure 12: Clinical Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009
    Figure 13: Clinical Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Figure 14: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 15: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 16: Urine Analysis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 17: Urine Analysis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 18: Clinical Chemistry, China, Company Share (%), 2009
    Figure 19: Genetic Testing, Market Segmentation
    Figure 20: Genetic Testing Market, China, Revenue Mix ($m), 2009
    Figure 21: Genetic Testing Market, China, Category Contribution (%), 2009
    Figure 22: Genetic Testing, China, Revenue ($m) by Segment, Historic, 2002-2009
    Figure 23: Genetic Testing, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Figure 24: Genetic Testing, China, Company Share (%), 2009
    Figure 25: Haematology, Market Segmentation
    Figure 26: Haematology Market, China, Revenue Mix ($m), 2009
    Figure 27: Haematology Market, China, Category Contribution (%), 2009
    Figure 28: Haematology, China, Revenue ($m) by Segment, Historic, 2002-2009
    Figure 29: Haematology, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Figure 30: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 31: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 32: Immunohaematology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 33: Immunohaematology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 34: Haemostasis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 35: Haemostasis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 36: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 37: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 38: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 39: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 40: Haematology, China, Company Share (%), 2009
    Figure 41: Histology And Cytology, Market Segmentation
    Figure 42: Histology And Cytology Market, China, Revenue Mix ($m), 2009
    Figure 43: Histology And Cytology Market, China, Category Contribution (%), 2009
    Figure 44: Histology And Cytology, China, Revenue ($m) by Segment, Historic, 2002-2009
    Figure 45: Histology And Cytology, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Figure 46: Histology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 47: Histology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 48: Histology And Cytology, China, Company Share (%), 2009
    Figure 49: Immuno Chemistry, Market Segmentation
    Figure 50: Immuno Chemistry Market, China, Revenue Mix ($m), 2009
    Figure 51: Immuno Chemistry Market, China, Category Contribution (%), 2009
    Figure 52: Immuno Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009
    Figure 53: Immuno Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Figure 54: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 55: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 56: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 57: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 58: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 59: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 60: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 61: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 62: Immuno Chemistry, China, Company Share (%), 2009
    Figure 63: Infectious Immunology, Market Segmentation
    Figure 64: Infectious Immunology Market, China, Revenue Mix ($m), 2009
    Figure 65: Infectious Immunology Market, China, Category Contribution (%), 2009
    Figure 66: Infectious Immunology, China, Revenue ($m) by Segment, Historic, 2002-2009
    Figure 67: Infectious Immunology, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Figure 68: Infectious Immunology, China, Company Share (%), 2009
    Figure 69: Microbiology Culture, Market Segmentation
    Figure 70: Microbiology Culture Market, China, Revenue Mix ($m), 2009
    Figure 71: Microbiology Culture Market, China, Category Contribution (%), 2009
    Figure 72: Microbiology Culture, China, Revenue ($m) by Segment, Historic, 2002-2009
    Figure 73: Microbiology Culture, China, Revenue ($m) by Segment, Forecast, 2009-2016
    Figure 74: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009
    Figure 75: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
    Figure 76: Microbiology Culture, China, Company Share (%), 2009
    Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),China In Vitro Diagnostics Market, 2009
    Figure 78: Siemens Healthcare, Company Share (%),China In Vitro Diagnostics Market, 2009
    Figure 79: Abbott Laboratories, Company Share (%),China In Vitro Diagnostics Market, 2009
    Figure 80: Beckman Coulter, Inc., Company Share (%),China In Vitro Diagnostics Market, 2009
    Figure 81: Sysmex Corporation, Company Share (%),China In Vitro Diagnostics Market, 2009
    Figure 82: Mindray Medical International Limited, Company Share (%),China In Vitro Diagnostics Market, 2009
    Figure 83: GlobalData Methodology